FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

Stocks have been hitting records in large part because Wall Street is expecting the economy to pull off a delicate balancing ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

The explosive rise of GLP-1 medications—such as Mounjaro, Ozempic, and Wegovy—has ignited more than just headlines. It has fundamentally shifted how Americans access and pay for medications, driving ...

The Danish pharmaceutical company Novo Nordisk is cutting 9,000 jobs, 4,000 of which will be outside Denmark. The company, ...

Novo Nordisk will lay off 9,000 employees worldwide as part of a restructuring plan, redirecting savings to diabetes and obesity drug growth.

The draft assessment finds that the popular weight loss drugs are costly but worth the price tag, while also urging for ...

The maker of the popular weight-loss drug Wegovy announced on Wednesday that it will be cutting 9,000 jobs in the company.

Novo Nordisk will cut 9,000 jobs, about 11.5% of its global workforce, as new CEO Maziar Mike Doustdar launches a major ...

The restructuring, which would eliminate 11% of the company's workforce, aimed to reduce organizational complexity and speed ...